en

PRODUCT DETAIL

Translarna 250 mg granulát na perorálnu suspenziu

Code 1457B
MA number EU/1/13/902/002
Product Form: gru por 30x250 mg (vre.Al)
MA Status: Ex - Conditional centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 87 - VARIA I
ATC:
M MUSCULO-SKELETAL SYSTEM
M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL
M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL
M09AX Other drugs for disorders of the musculo-skeletal
M09AX03 Ataluren
Shelf life: 48
Container: sachet Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 31.07.2014
Validity: 05.08.2023
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 04.07.2022
eu-flag.png sk-flag.png